Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction

European Journal of Heart Failure

Volumn 11, Issue 7, 2009, Pages 691-698

  Yao, Kang ^a   Huang, Rongchong ^a,b   Sun, Aijun ^a   Qian, Juying ^a   Liu, Xuebo ^a   Ge, Lei ^a   Zhang, Yiqi ^a   Zhang, Shuning ^a   Niu, Yuhong ^a   Wang, Qibing ^a   Zou, Yunzeng ^a   Ge, Junbo ^a  

^a FUDAN UNIVERSITY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

BMC; Cell therapy; Large; Myocardial infarction; Repeated

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GADODIAMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THALLIUM 201;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART PERFUSION; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT ELEVATION; TREATMENT OUTCOME; ADOLESCENT; ANALYSIS OF VARIANCE; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CHINA; CONFIDENCE INTERVAL; HEART BUNDLE BRANCH BLOCK; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANGIOPLASTY, BALLOON, CORONARY; BONE MARROW TRANSPLANTATION; BUNDLE-BRANCH BLOCK; CHINA; CONFIDENCE INTERVALS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 67650085037     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfp062     Document Type: Article

References (21)

1. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, Kogler G, Wernet P. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106:1913-1918.
2. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, Grunwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher AM. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002; 106:3009-3017.
3. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004; 364:141-148.
4. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, Yu JT, Corti R, Mathey D, Hamm CW, Suselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM. Intracoronary bone marrow derived progenitor cells in acute myocardial infarction. N Eng J Med 2006; 355:1210-1221.
5. Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, Kalantzi M, Herbots L, Sinnaeve P, Dens J, Maertens J, Rademakers F, Dymarkowski S, Gheysens O, Van Cleemput J, Bormans G, Nuyts J, Belmans A, Mortelmans L, Boogaerts M, Van de Werf F. Autologous bone marrow-derived stem cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomized controlled trial. Lancet 2006; 367:113-121.
6. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Fjeld JG, Smith HJ, Taraldsrud E, Gr0gaard HK, Bj0rnerheim R, Brekke M, Muller C, Hopp E, Ragnarsson A, Brinchmann JE, Forfang K. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006; 355:1199-1209.
7. Meluzfn J, Mayer J, Groch L, Janousek S, Hornacek I, Hlinomaz O, Kala P, Panovsky R, Prasek J, Kamfnek M, Stanfcek J, Klabusay M, Korfstek Z, Navratil M, Dusek L, Vinklarkova J. Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. Am Heart J 2006; 152:975.e9-975.e15.
8. Britten MB, Abolmaali N, Assmus B, Lehmann R, Honold J, Schmitt J, Vogl TJ, Martin H, Schachinger V, Dimmeler S, Zeiher AM. Infarct remodeling after intra- coronary progenitor cell treatment in patients with acute myocardial infarction(TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 2003; 108:2212-2218.
9. Ge J, Li Y, Qian J, Shi J, Wang Q, Niu Y, Fan B, Liu X, Zhang S, Sun A, Zou Y. Efficacy of Emergent Transcatheter Transplantation of Stem Cells for Treatment of Acute Myocardial Infarction (TCT-STAMI). Heart 2006; 92:1764-1767.
10. Klein C, NekollaSG, Bengel FM,Momose M,Sammer A,HaasF,SchnackenburgB, Delius W, Mudra H, Wolfram D, Schwaiger M. Assessment ofmyocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002; 105:162-167.
11. Wollert KC, Drexler H. Clinical applications of stem cells for the heart. Circ Res 2005; 96:151 -163.
12. Tambara K, Sakakibara Y, Sakaguchi G, Lu F, Premaratne GU, Lin X, Kazunobu N, Masashi K. Transplanted skeletal myoblasts can fully replace the infracted myocardium when they survive in the host in large numbers. Circulation 2003; 108:259-263.
13. Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B,Ganser A, Knapp WH, Drexler H. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005; 111:2198-2202.
14. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, Hecker H,Schaefer A, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary bone marrow cell transfer after myocardial infarction eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006; 113:1287-1294.
15. Premaratne GU, Tambara K, Fujita M, Lin X, Kanemitsu N, Tomita S, Sakaguchi G, Nakajima H, Ikeda T, Komeda M. Repeated implantation is a more effective cell delivery method in skeletal myoblast transplantation for rat myocardial infarction. Circ J2006; 70:1184-1189.
16. Korf-Klingebiel M, KempfT, Sauer T,Brinkmann E, Fischer P, MeyerGP, Ganser A, Drexler H, Wollert KC. Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J2008; 29:2851 -2858.
17. Berry MF, Engler AJ, Woo YJ, Pirolli TJ, Bish LT, Jayasankar V, Morine KJ, Gardner TJ, Discher DE, Sweeney HL. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol 2006; 290:H2196-H2203.
18. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410:701 -705.
19. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, BurkhoffD, WangJ, Homma S, Edwards NM, Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7:430-436.
20. Muller-Ehmsen J, Whittaker P, Kloner RA, Dow JS, Sakoda T, Long TI, Laird PW, Kedes L. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. JMol Cell Cardiol 2002; 34:251-253.
21. Diederichsen ACP, M0ller JE, Thayssen P, Junker AB, Videbask L, Saskmose SG, Barington T, Kristiansen M, Kassem M. Effect of repeated intracoronary injection of bone marrow cells in patients with ischaemic heart failure. The Danish Stem Cell study-Congestive Heart Failure trial (DanCell-CHF). Eur J Heart Fail 2008; 10:661 -667.